» Articles » PMID: 20337922

Quality of Life in Patients with Various Liver Diseases: Patients with HCV Show Greater Mental Impairment, While Patients with PBC Have Greater Physical Impairment

Overview
Journal J Viral Hepat
Specialty Gastroenterology
Date 2010 Mar 27
PMID 20337922
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Little is known comparing and contrasting quality of life (QoL) in patients with hepatitis C, compared to patients with other liver diseases. We performed two independent prospective cross-sectional studies including 511 and 284 patients with different forms of liver diseases. SF-36 was used in both studies. Fatigue Impact Score, WHO-BREF and Hospital Anxiety and Depression Scale (HADS) were used in either study only. In both studies, HCV-positive patients scored worse in the mental aspects of health-related QoL compared to other liver diseases, except for HBV in one study. Surprisingly, in both studies, quality of life was also significantly impaired in patients with viral clearance after interferon therapy but not after spontaneous clearance. Furthermore, patients with primary biliary cirrhosis showed significantly better mental health but significantly worse physical well-being. Liver diseases differ in their form of impaired QoL. In HCV, this impairment might not always return to normal after treatment-induced viral clearance. This may suggest that HCV either may not be involved in QoL impairment or may induce a process which persists after viral clearance in some patients.

Citing Articles

Cognitive Impairments in Viral Hepatitis Patients: Causes, Manifestations, and Impact on Quality of Life.

Polukchi T Rambam Maimonides Med J. 2025; 16(1).

PMID: 39879545 PMC: 11779499. DOI: 10.5041/RMMJ.10539.


The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson Disease.

Camarata M, Ala A, Coskun A, Deng Y, Gonzalez-Peralta R, Maciejewski K J Acad Consult Liaison Psychiatry. 2021; 62(5):528-537.

PMID: 34044196 PMC: 11165927. DOI: 10.1016/j.jaclp.2021.04.004.


Quality of life in primary sclerosing cholangitis: a systematic review.

Marcus E, Stone P, Krooupa A, Thorburn D, Vivat B Health Qual Life Outcomes. 2021; 19(1):100.

PMID: 33743710 PMC: 7981996. DOI: 10.1186/s12955-021-01739-3.


A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study.

Semmo N, Mullhaupt B, Ruckstuhl L, Magenta L, Clerc O, Torgler R PLoS One. 2020; 15(11):e0241267.

PMID: 33147283 PMC: 7641439. DOI: 10.1371/journal.pone.0241267.


Outcomes of Palliative Care Consultations for Hospitalized Patients With Liver Disease.

Ufere N, ORiordan D, Bischoff K, Marks A, Eneanya N, Chung R J Pain Symptom Manage. 2019; 58(5):766-773.

PMID: 31326503 PMC: 6823143. DOI: 10.1016/j.jpainsymman.2019.07.011.